EBR Systems EBRCZ
EBRCZ
$0.21 -0.03 (-11.02%)
As of: Aug 19, 2026 · 11:38 AM EDT

EBR Systems (EBRCZ) Return on Sales (2025 - 2026)

EBR Systems (EBRCZ) posted Return on Sales of 0.07% for Q1 2026, down 77.6% sequentially from 0.04% in Q4 2025.

EBR Systems (EBRCZ) Return on Sales (2025 - 2026) Analysis & Trends

EBR Systems has reported Return on Sales for 2 years, with the latest figure at 0.07% in Q1 2026.

  • Quarterly Return on Sales changed N/A year-over-year to 0.07% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.11% (changed N/A YoY) and the FY2025 annual result came in at 0.24%, changed N/A from the prior year.
  • Return on Sales retreated to 0.07% in Q1 2026 per EBRCZ's latest filing, from 0.04% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.04% in Q4 2025 and troughed at 0.71% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 0.00%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 0.00%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 0.00%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 0.00%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 0.00%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 0.00%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 0.00%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 0.00%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 0.00%
10 EBR Systems 11.82 Mn 11.82 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.07%
Dec 31, 2025 -0.04%
Sep 30, 2025 -0.24%
Jun 30, 2025 -0.71%